179 related articles for article (PubMed ID: 12757253)
1. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
Toro JR; Sanchez S; Turiansky G; Blauvelt A
Dermatol Clin; 2003 Apr; 21(2):301-9. PubMed ID: 12757253
[TBL] [Abstract][Full Text] [Related]
2. Treatment of verruca vulgaris with topical cidofovir.
Zabawski EJ; Sands B; Goetz D; Naylor M; Cockerell CJ
JAMA; 1997 Oct; 278(15):1236. PubMed ID: 9333263
[No Abstract] [Full Text] [Related]
3. Local treatment of HPV-induced skin lesions by Cidofovir.
Stragier I; Snoeck R; De Clercq E; Van Den Oord JJ; Van Ranst M; De Greef H
J Med Virol; 2002 Jun; 67(2):241-5. PubMed ID: 11992585
[TBL] [Abstract][Full Text] [Related]
4. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
[No Abstract] [Full Text] [Related]
5. Successful treatment of recalcitrant condyloma with topical cidofovir.
Hengge UR; Tietze G
Sex Transm Infect; 2000 Apr; 76(2):143. PubMed ID: 10858720
[No Abstract] [Full Text] [Related]
6. Topical cidofovir is effective in treating extensive penile condylomata acuminata.
Schürmann D; Bergmann F; Temmesfeld-Wollbrück B; Grobusch MP; Suttorp N
AIDS; 2000 May; 14(8):1075-6. PubMed ID: 10853999
[No Abstract] [Full Text] [Related]
7. [Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
Toutous-Trellu L; Hirschel B; Piguet V; Schiffer V; Saurat JH; Pechère M
Ann Dermatol Venereol; 2004 May; 131(5):445-9. PubMed ID: 15235531
[TBL] [Abstract][Full Text] [Related]
8. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Zabawski EJ; Cockerell CJ
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):741-5. PubMed ID: 9810890
[TBL] [Abstract][Full Text] [Related]
9. Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata.
Coremans G; Margaritis V; Snoeck R; Wyndaele J; De Clercq E; Geboes K
Dis Colon Rectum; 2003 Aug; 46(8):1103-8; discussion 1108-9. PubMed ID: 12907906
[TBL] [Abstract][Full Text] [Related]
10. Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection.
Martinelli C; Farese A; Mistro AD; Giorgini S; Ruffino I
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):568-9. PubMed ID: 11843219
[TBL] [Abstract][Full Text] [Related]
11. Topical cidofovir for condylomata acuminata of the genitalia in a 3-year-old child.
Calisto D; Arcangeli F
J Am Acad Dermatol; 2003 Dec; 49(6):1192-3. PubMed ID: 14639419
[No Abstract] [Full Text] [Related]
12. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
[TBL] [Abstract][Full Text] [Related]
13. Topical cidofovir for bowenoid papulosis in an HIV-infected patient.
Descamps V; Duval X; Grossin M; Crickx B; Leport C
Br J Dermatol; 2001 Mar; 144(3):642-3. PubMed ID: 11260042
[No Abstract] [Full Text] [Related]
14. A review of topical and intralesional cidofovir.
Zabawski EJ
Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.
Matteelli A; Beltrame A; Graifemberghi S; Forleo MA; Gulletta M; Ciravolo G; Tedoldi S; Casalini C; Carosi G
Sex Transm Dis; 2001 Jun; 28(6):343-6. PubMed ID: 11403192
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
18. Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade).
AIDS Treat News; 1997 Feb; (No 264):5. PubMed ID: 11364104
[TBL] [Abstract][Full Text] [Related]
19. NDA filed to treat refractory herpes.
AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361756
[No Abstract] [Full Text] [Related]
20. Cidofovir and surgery for genital warts.
TreatmentUpdate; 2002 Feb; 14(2):3-4. PubMed ID: 12691039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
